Search

Cryopreserved human iPSC-derived cortical neurons, glutamatergic or GABAergic, shipped by vial.

Cryopreserved human iPSC-derived spinal motor neurons, including ALS patient and isogenic control lines.

Expandable human iPSC-derived neural stem cells for customers who want to differentiate in-house.

Cryopreserved human iPSC-derived astrocytes for neuronal co-culture and glial studies.

Cryopreserved human iPSC-derived ventricular or atrial cardiomyocytes, spontaneously contractile after plating.

Myogenic progenitor cells for casting skeletal muscle tissue, from iPSC-derived catalog vials up to GMP-grade primary production.

Undifferentiated human induced pluripotent stem cell lines as a starting material for customer-run differentiation.

Living, metabolically active 3D human epidermal tissue on culture inserts, delivered on a weekly production cadence.

Living pseudostratified, ciliated human airway tissue cultured at an air-liquid interface.

Living human small intestine or colon epithelium in planar or crypt format for permeability, metabolism and barrier work.

Pre-formed 3D human liver spheroids delivered ready for dosing, on a published production schedule.

Microfluidic plates arriving with tissue already seeded and perfused, so the buyer never handles cells or ECM.

Aligned, mechanically anchored, electrically stimulable engineered skeletal muscle tissue built and force-tested against a written specification.

Motor neurons and myotubes co-cultured in a compartmentalised device so that neural stimulation drives muscle contraction.

Human neurons plated onto multi-electrode arrays, matured to spontaneous network activity, and delivered as a live recording-ready culture.

Ground-up design, prototyping and cleanroom production of custom PDMS culture devices, from single prototypes to batch runs.

Off-the-shelf micropillar casting devices in which the customer forms their own anchored 3D muscle tissue.

Electrical pacing lids and contractile-force measurement instruments for maturing and phenotyping engineered tissue.

Tendon, ligament, cartilage and other animal tissues collected, processed and shipped to a written customer specification.

Consented human tissue, adipose, biofluids and disease-state specimens sourced from banked inventory or collected prospectively.

Outsourced expansion of your cells to a target cell number, cryopreserved into a documented bank at research or GMP grade.

Outsourced directed differentiation of iPSCs or progenitors into a specified mature cell type, delivered as cells or as a formed tissue.

Independent release testing of cells or tissue against compendial methods before you accept delivery.

Sectioning, staining, multiplexed immunofluorescence, 3D imaging and quantitative image analysis of delivered tissue.

Functional acceptance testing of engineered tissue — twitch and tetanic force, fatigue, damage, and electrophysiological activity.

Packaging, documentation and time-critical shipping of live tissue on cold packs or frozen material on dry ice or in vapour-phase nitrogen.

A genuinely even-handed head-to-head of the main human iPSC-derived neuron suppliers — price per million, purity specification, subtype breadth, line provenance, published electrophysiology, licensing and minimum order — with a clear statement of where each one is strongest.

A landscape map of biohybrid actuator work — which groups build what, from which cell source, with what published force — and the honest supply-side answer: no vendor sells a living actuator, so every project is an integration job.

Eight organ-on-chip platforms against throughput, perfusion mechanism, membrane versus scaffold-free architecture, imaging compatibility, open versus closed consumables and published tissue models. No vendor publishes consumable pricing — that column is honestly empty.

Published twitch and tetanic forces for engineered skeletal muscle, normalised to specific force in mN/mm² alongside cross-sectional area and stimulation protocol, with a citation on every row. The reference table for anyone writing a force specification.

A head-to-head of the validated reconstructed human epidermis models — barrier function and ET-50 acceptance ranges, protocol parameters, OECD TG 439 and TG 431 validation status, formats, lead time and what is actually published about price.

Four cell sourcing routes for a biohybrid muscle actuator compared on cost, maturation time, published force, culture burden, approval burden and who will actually supply them. C2C12 is the default and it is a mouse cell line.

A transparent total-cost-of-ownership model for making iPSC-derived neurons in-house versus buying them: reagents, media, line licence, technician hours, facility charge, failure rate and QC, against catalogue price, with breakeven by batches per year. Every unit price is sourced and dated.

What master cell banks, working cell banks and research-use banks cost, what testing is bundled into each, and where the published prices stop and the quote-only wall begins. Sourced and dated figures from named providers and published institutional rate cards.

A dated, sourced index of what cells, tissue models, QC testing, cell banking and custom culture devices actually cost. Every band comes from a supplier page or published rate card we fetched, with the observation date recorded.

Published prices for cell line authentication (STR), mycoplasma detection, sterility, karyotyping and endotoxin testing, by assay, method, provider, price and turnaround, with a note on when each test becomes required rather than optional.

Published list prices for human iPSC-derived neurons, normalised to cost per million cells, across named suppliers. Recorded from supplier sources with the date and URL for each figure.

Published list prices for human iPSC-derived cardiomyocytes from Axol Bioscience, BPS Bioscience and FUJIFILM Cellular Dynamics, normalised per million cells, with purity specifications and the source and date for every figure.

Published fabrication pricing for custom microfluidic and culture devices, split into non-recurring tooling and per-part cost, by method (soft lithography, injection moulding, laser, 3D printing) across volume tiers of 1, 10, 100 and 1,000 parts. Every figure sourced and dated.

The three main routes to human neurons in vitro compared on time to maturity, purity, subtype fidelity, cost, network activity and when each is appropriate. NGN2 induction is fast and homogeneous; developmental cortical protocols run around 80 days.

A specification and price comparison of reconstructed human epidermis models — MatTek EpiDerm, EPISKIN SkinEthic RHE, Phenion FT and others — with OECD validation status, kit format, shipping cadence and shelf life, and an honest account of which suppliers publish a price and which do not.

An A–Z reference of terms used in buying and specifying engineered living components: cells, engineered tissue, culture devices and the QC, licensing and logistics vocabulary around them. Over 60 terms, each with a one-line definition.

Post-thaw viability is the percentage of cells in a thawed cryopreserved vial judged alive by a stated assay at a stated time. Method comparison across trypan blue, AO/PI and plating efficiency, and why vendor numbers are not comparable.

MEA-ready is an undefined marketing term for neuron products sold for multielectrode array use. Here is the checklist of seven attributes that actually determine whether a product will produce network activity on an MEA.

An engineered living component is a living biological construct produced to a written specification, intended to function as a part within a larger system. Definition, taxonomy, boundary cases, and relation to tissue engineering, biofabrication and synthetic biology.

RUO cells are supplied for research use only with no regulatory manufacturing standard behind them; GMP cells are manufactured under a quality system for clinical use. Comparison of documentation, testing, price, permitted use, and when RUO is sufficient.

Which fabrication method suits your feature size, what each fabricator will and will not take on, and the twelve-item specification checklist that makes two microfluidic quotes comparable instead of merely different.

Who will culture, expand, differentiate, bank or plate cells for you, at what scale, under RUO or GMP, and on what price basis. Cook MyoSite runs a 3,470 sq ft ISO 7 / ISO 5 cleanroom for muscle cell manufacture; almost nobody publishes a rate.

A service taxonomy for cell and tissue work: what each service is priced on, how long it takes, and the specific conditions under which outsourcing beats doing it in-house. Includes the three cases where in-house is clearly correct.

A complete field checklist for requesting quotes on cells, engineered tissue and custom culture devices, plus a fully worked example RFQ. Written so two suppliers quoting the same document produce comparable numbers.

A PDMS device quote has six cost centres — master, casting, bonding, surface treatment, sterilisation and QC. Most first-round quotes price two of them. This page shows the full anatomy and a comparable quote structure you can send to any shop.

Fourteen organisations that will quote tissue engineering work, mapped against scaffold, bioprint, muscle, skin, vascular and organ-on-chip capability, regulatory scope, instrumentation and engagement size — including which parts of this market have closed down.

A directory of named human iPSC-derived neuron suppliers with the columns that actually matter — subtypes offered, published purity, whether MEA data is published, line provenance, licensing posture, minimum order, lead time, region, RUO/GMP status and price band.

An availability map of engineered human tissue by type — which are shipped as off-the-shelf living products, which are custom programmes, and which exist only in academic laboratories — with the supplier count and the evidence behind each classification.

Three routes to a culture device: buy off the shelf, modify something that exists, or fabricate from scratch. This page sets out what each route costs, how long it takes, and the questions that decide which one you are actually on.

eNUVIO OMEGA-MP is USD $440.00 for four devices and eight experiments — the only public price in the category. This compares it against OMEGA96-MP, the Curi Bio Mantarray plate kits and custom PDMS posts on well count, post stiffness, force readout and tissue volume.

What Wetware World brokers, how long each category actually takes, and which categories have a catalogue price versus which require an RFQ. A category matrix built from verified supplier data.

One supplier, myriamed, sells finished engineered skeletal muscle off a public storefront at EUR 1,400 per tissue. It publishes no force specification. This page names that option, the casting devices you can cast your own in, who will quote a custom programme, and the real published force numbers so you can judge a spec.

A supplier table for human skeletal myoblasts and muscle-derived cells covering donor disclosure, passage at ship, purity marker and threshold, whether fusion index is reported, price and lot variability — with an honest account of what is not specified anywhere.

An availability table for human iPSC-derived cortical neurons across named suppliers — subtype, published purity specification, markers, format, lead time, licence class and price band, each traced to the supplier source it came from.

What research-use cell line terms actually permit, quoted from published ATCC, EBiSC, Coriell and bit.bio agreements. The right to sell a differentiated derivative is almost never included in the purchase price.

A compatibility matrix of iPSC neuron products against Axion Maestro, MaxWell MaxTwo and Multi Channel Systems MEA platforms — plate formats, electrode counts, seeding densities, days to bursting and co-culture requirements, with an explicit statement of why "MEA-ready" is not a defined term.

A 15-item quality control checklist for buying cells: what each item is, why it matters, what an acceptable specification looks like, the red flag to watch for, and whether suppliers provide it as standard.

An end-to-end procurement flow for engineered living components, from specification through supplier selection, licensing, QC, shipping and acceptance, with a checklist for each of the eight stages.

PDMS absorbs hydrophobic small molecules badly enough to invalidate pharmacology. This is the material matrix — absorption, optical clarity, gas permeability, autofluorescence, bondability, scalability and cost per part — with the published absorption data laid out properly.

The four shipment formats for living material compared on viability risk, cost, customs and IATA treatment, and what to test on arrival. Includes the verified MatTek cold-chain model: 4°C on agarose gels, fixed weekly cadence, four-day shelf life including transit.

Every organisation we hold evidence for across cells, tissue models, contractile tissue, culture devices, native tissue, contract manufacturing, QC and cold chain — with what each actually supplies, its region, whether it publishes a catalogue price, its RUO or GMP posture, and how strong our evidence is. Including the ones that have exited.

A sourcing table for human iPSC-derived cardiomyocytes across named suppliers — ventricular, atrial and nodal subtype availability, published purity specifications, beating and assay-ready timing, MEA and calcium-imaging validation, and list prices with the source and date for every figure.

Published list prices for human iPSC-derived spinal motor neurons from iXCells, bit.bio, Axol and others, normalised per million cells, with the marker evidence each supplier publishes, the differentiation route where disclosed, and disease and isogenic line pricing.

Seven providers of contract primary cell isolation compared on tissue types, donor sourcing and consent posture, yield expectations and price basis. Includes what a defensible consent chain looks like and why nobody guarantees yield.

Seven providers of contract iPSC differentiation compared on lineages offered, whether they will work on your line or insist on theirs, QC deliverables, published timelines and price basis. Includes the only published phase durations in the category.

Ten organ-on-chip providers mapped against platform lock-in, tissue types supported, perfusion mechanism, imaging compatibility, whether they sell a product or a service, and the engagement model each will actually sign. Plus the scoping questions that decide the price.

Observed lead times across 26 offerings — catalogue cells, living tissue models, engineered tissue, custom microfabrication, contract culture and QC — with what actually drives the variance and why a six-week quote becomes eleven weeks.

A normalisation worksheet for custom biology quotes: the twelve line items that must be present, the terms that decide who pays for a failed batch, and two worked examples — quotes that look different and are identical, and quotes that look identical and are not.

Three culture architectures compared on physiological relevance, cost per data point, throughput and hands-on time — including an explicit account of when a Transwell insert is the right and cheaper answer, which is more often than the field admits.

Prices and specifications for human iPSC-derived astrocytes, microglia, oligodendrocytes and OPCs across named suppliers, plus the neuron-to-astrocyte co-culture ratios and seeding densities used in published multielectrode array work, with citations.

A buying guide for reconstructed human epidermis — which models hold OECD TG 439 and TG 431 validation, what a kit contains, verified shipping cadence and shelf life, QC-on-arrival procedure, and the one supplier that publishes a full price list.

Published plate formats and electrode counts for Axion Maestro, MaxWell MaxOne and MaxTwo, Multi Channel Systems, 3Brain CorePlate and Alpha MED Scientific MED64, with coating requirements and which cell products have published protocols on each.

Reference tables of published growth areas per well for 6 to 384-well plates and MEA formats, sourced seeding densities for neurons and cardiomyocytes, cells per well, wells per one-million-cell vial, and a worked 48-well MEA calculation with honest correction factors.

The requirements a reconstructed human epidermis model must meet under OECD Test Guideline 439 — tissue construction, barrier function expressed as ET-50 or IC50, the MTT viability assay, controls, run acceptance criteria and the prediction model — plus which commercial models hold validation and how TG 431 relates.

Who supplies cells already in the plate, in which formats, live or frozen, and how to work out whether the premium beats your own technician hours. An under-served niche with a genuinely narrow set of cases where it is the right purchase.

The commercial and academic landscape for neurons-as-compute: Cortical Labs CL1 and Cortical Cloud, FinalSpark Neuroplatform, and the general-purpose HD-MEA route. Substrate, electrode counts, access model and published prices, with sources and dates.

A sourcing guide to ready-to-use human liver microtissues and spheroids — InSphero 3D InSight, MatTek HUREL micro livers, CN Bio PhysioMimix liver plates and others — with donor pooling, longevity in culture, published per-plate prices, production schedules and shipping arrangements.

A sourcing guide to engineered heart tissue — myriamed myrPlate and myrTissue-Cardio with published prices, Curi Bio Mantarray, Ncardia and DiNABIOS (formerly EHT Technologies) — covering format, force readout, instrument lock-in, lead time and what each route actually commits you to.

A comparison of fourteen 3D tissue model suppliers — MatTek, EPISKIN, InSphero, MIMETAS, Emulate, CN Bio, TissUse, Altis, Visikol, Xellar, Phenion, J-TEC, myriamed and eNUVIO — on tissue types, format, whether they ship finished tissue or an empty device, custom capability and published price band.

A comparison matrix of 3D skeletal muscle models — Curi Bio Mantarray, eNUVIO OMEGA-MP, Duke myobundles, myriamed myrPlate and myrTissue-Skeletal, and CYTOO MyoScreen — on cell source, device, force readout, maturation time, throughput and cost per data point, with published force figures.

The ANSI/SLAS microplate standards give five numbers a custom culture device must respect to work with the imager, the liquid handler and the plate reader you already own. This is what each one is, where the tolerance sits, and which failures are recoverable.

A sourcing guide to off-the-shelf human airway tissue — MatTek EpiAirway, EpiNasal and EpiAlveolar, Epithelix MucilAir, SmallAir and AlveolAir — with verified TEER release criteria, culture longevity, donor disease panels, anatomical region mapping and the post-shipment QC problem nobody mentions.

A sourcing guide to reconstructed human cornea-like epithelium — EpiOcular, SkinEthic HCE, LabCyte CORNEA-MODEL24 and MCTT HCE — with the OECD TG 492 prediction model cut-offs, published QC batch release ranges, exposure protocols and what the guideline says these models cannot do.

A sourcing guide to human intestinal tissue models — Altis RepliGut Planar and Crypt, MatTek EpiIntestinal, MIMETAS OrganoReady Colon and CN Bio gut plates — covering regional identity, the planar-versus-organoid geometry decision, published Caco-2 comparisons, time to a working barrier and what to specify in a quote.

A complete parts list for one engineered muscle actuator, from cells to force readout, with a published price where one exists and an explicit "quote only" where it does not. Verified prices: eNUVIO $440, ATCC $577, myriamed EUR 1,400.

What an engineering group must acquire, learn and staff before it can make a living actuator — and the one verified price that finally makes the make-versus-buy comparison answerable: myriamed lists a finished skeletal muscle tissue at EUR 1,400.

Cardiac muscle contracts by itself and never stops. Skeletal muscle does nothing until you tell it to, then does exactly that. Published forces, control models, lifetimes and commercial supply for both, with a citation on every claim.

A rocker costs nothing per channel and gives you bidirectional gravity flow. A pressure-driven pump costs five figures and gives you a defined shear stress. This sets out the four perfusion routes, their published shear stress relationships and the live-verified prices.

Plasma treatment turns PDMS hydrophilic and it starts reverting within minutes. This sets out the published contact-angle data, the storage protocols that extend the window, the ECM coating options, and what to write into a device specification so the surface arrives usable.

Corning publishes growth areas, pore densities and membrane characteristics for every Transwell format. This is that data assembled, plus why a TEER value measured with chopstick electrodes is not comparable to one measured any other way.

AggreWell, Sphericalplate 5D, Corning Elplasia, InSphero Akura and Gri3D produce between one and 12,000 spheroids per vessel. This compares published microwell counts, cell loading ranges and materials, with the live-verified list prices where they exist.

A directory of human iPSC line sources — WiCell, Coriell, RIKEN BRC, EBiSC, ATCC and the commercial banks — with distribution fees at both academic and commercial tiers, the agreement each requires, who owns the underlying reprogramming patents, and what each will not let you do with a derivative.

A directory of named primary human cell suppliers with the columns that decide whether a lot is usable — passage at ship, guaranteed population doublings, the pathogen panel, donor disclosure, delivery format and published price, with the source and date for every figure.

A sourcing guide to human mucosal tissue models — MatTek EpiOral, EpiGingival and EpiVaginal, EPISKIN SkinEthic HGE, HO2E, HBE and HVE — covering non-keratinised versus keratinised mucosa, why most of this category sits outside OECD validation, and what to specify when there is no acceptance criterion to point at.

The practical difference between self-organising organoids and engineered tissue constructs — apical access, assay compatibility, batch variability, Matrigel dependence and the oxygen diffusion limit — and how the choice determines which suppliers and which assays are available to you.

Living actuators run at 37 °C in buffered media inside a sterile incubator, and published untethered lifetimes are measured in days. The environmental constraints, the one documented ambient exception, and what that means for device design.

Light-driven muscle actuation buys spatial addressing that electrodes cannot give, at the cost of a genetic modification step. Published forces, the 84 percent figure against electrical stimulation, and the four things you must actually acquire.

Autoclaving is free and deforms thermoplastics. Gamma is a service and changes polymer crosslinking. EO leaves residuals with published limits. This sets out the five sterilisation routes against material compatibility, surface treatment survival and what to write into a device specification.

A directory of organoid model suppliers, biobanks and expansion services — adult stem cell versus iPSC-derived routes, tissue coverage, whether models are sold or only screened against, and the HUB technology licence that separates academic purchase from commercial use.

Living tissue is manufactured to a calendar, not held in inventory. The published shipping cadences, order-by dates, shelf lives and post-shipment QC windows from MatTek, Epithelix and InSphero — and how to plan a study around a supply that does not exist until it is made.

Engineered tissue stops at roughly 100–200 µm without a blood supply. What that physical limit means commercially, what vascular models actually ship today, what the bioprinting literature has demonstrated, and how to specify a thick-tissue project honestly.

Putting motor neurons in command of engineered muscle adds a biological control layer to a biohybrid device. What the published work achieved, how the curare test proves a junction is real, and what you have to buy to attempt it.

Commercial resin printers resolve at 50 µm pixels, not at microfluidic scale — research printers reach 18 µm and below. This sets out the resolution ceiling, the resin cytotoxicity problem, the published biocompatibility data and when printing beats moulding.

A directory of extracellular matrix and hydrogel suppliers for 3D culture — basement membrane extracts, animal and human collagens, GelMA and photo-crosslinkable inks, and fully defined synthetic systems — with species of origin, whether stiffness is a specified parameter, and published prices.

A directory of 3D bioprinter and bioink suppliers covering extrusion, light-based and volumetric platforms, with published consumable prices, which vendors gate instrument pricing behind a quote, and a dated record of the exits — including the Allevi end-of-service-life date that has already passed.

A directory of human and animal biospecimen suppliers — marketplaces, biorepositories, direct-to-patient collectors and animal tissue catalogues — covering prospective versus inventory collection, contracting structure, specimen classes, published prices and which vendors block verification.